## Correct Answer: B. Once in three weeks for 5 years or till the age of 18, whichever is longer This child presents with acute rheumatic fever (ARF) without carditis—classified as **low-risk ARF**. According to Indian guidelines (RNTCP/IAP) and Harrison's criteria, secondary prophylaxis duration depends on whether carditis is present. In the absence of carditis, the recommendation is **benzathine penicillin G 6,00,000 IU intramuscularly once every 3 weeks for 5 years or until age 18, whichever is longer**. This is the standard secondary prophylaxis regimen in India for ARF without carditis. The rationale is that the risk of recurrence decreases significantly after 5 years in non-carditis cases, and by age 18, most patients have completed their vulnerable period. The 6,00,000 IU dose is the standard Indian formulation (1.2 million IU is the global standard, but 6,00,000 IU is commonly used in India). This regimen balances preventing recurrent ARF while avoiding unnecessary prolonged therapy in a child with no evidence of permanent cardiac damage. ## Why the other options are wrong **A. Immediately** — This is incorrect because 'immediately' refers to the timing of the FIRST dose, not the frequency of prophylaxis. While the first dose should be given as soon as ARF is diagnosed, the question asks about the **frequency and duration** of prophylaxis. This is an NBE trap that conflates initial treatment with long-term prophylaxis strategy. **C. Thrice weekly lifelong** — This is incorrect and represents **over-treatment**. Lifelong prophylaxis is reserved only for ARF with **established carditis and valvular disease** (secondary prophylaxis in RHD). Since this child has no carditis or valvular disease, lifelong therapy is not indicated. Thrice-weekly dosing is also not standard; the correct frequency is once every 3 weeks. This option confuses secondary prophylaxis (ARF without carditis) with tertiary prophylaxis (RHD with carditis). **D. Once in three weeks for 10 years or till the age of 25, whichever is longer** — This represents **prolonged prophylaxis** appropriate for ARF **with carditis** (5 years or until age 21 minimum, often extended to 10 years or age 25). Since this child has no evidence of carditis, the shorter duration (5 years or age 18) applies. This option is a common NBE trap that extends the prophylaxis duration inappropriately for a non-carditis case, confusing the stratification based on carditis presence. ## High-Yield Facts - **ARF without carditis**: Secondary prophylaxis is 6,00,000 IU benzathine penicillin IM once every 3 weeks for 5 years or until age 18, whichever is longer. - **ARF with carditis (RHD)**: Secondary prophylaxis is extended to 10 years or until age 21–25, whichever is longer. - **Benzathine penicillin dosing in India**: 6,00,000 IU (or 1.2 million IU) IM is the standard; oral penicillin V is NOT adequate for secondary prophylaxis. - **Recurrence risk**: Without prophylaxis, recurrence rate in ARF is 30–50%; with prophylaxis, it drops to <5%. - **Carditis as stratifier**: Presence or absence of carditis on initial presentation is the key determinant of prophylaxis duration in ARF. ## Mnemonics **ARF Prophylaxis Duration Rule** **No Carditis = 5 years or age 18** | **With Carditis = 10 years or age 21–25**. Remember: Carditis = Chronic (longer duration). **Benzathine Penicillin Frequency** **Every 3 weeks, not weekly or daily**. Think: "3 weeks = 21 days = 3 × 7 days" — a simple divisible interval for compliance in Indian outpatient settings. ## NBE Trap NBE pairs ARF without carditis with lifelong or 10-year prophylaxis (options C and D) to trap students who confuse secondary prophylaxis (ARF alone) with tertiary prophylaxis (RHD with carditis). The presence or absence of carditis is the critical discriminator that many students miss. ## Clinical Pearl In Indian pediatric practice, the 5-year cutoff for non-carditis ARF is crucial because many rural children present late with only fever and arthralgia, and over-treating them with lifelong penicillin increases cost and non-compliance. The "age 18 or 5 years, whichever is longer" rule ensures that even a 14-year-old diagnosed with ARF receives at least until age 18, capturing the high-risk adolescent period. _Reference: Harrison Ch. 329 (Acute Rheumatic Fever); IAP Textbook of Pediatrics; KD Tripathi Ch. 45 (Penicillins)_
Sign up free to access AI-powered MCQ practice with detailed explanations and adaptive learning.